ASSENT- 3 andASSENT- 3 PLUS investigators. Age, outcomes, and treatment effects of fibrinolytic and anti-thrombotic combinations: findings from Assessment of the Safety and Efficacy of a New Thrombolytic (AS-SENT)-3 andASSENT- 3 PLUS - Sinnaeve, PR; Huang, Y; Bogaerts, K (Am Heart J, 2006)
e1-9..